Carregant...
MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1
Oxaliplatin is a commonly used chemotherapeutic drug for the treatment of advanced colorectal cancer. However, acquired drug resistance against oxaliplatin remains a major obstacle for efficient use of it, and mechanisms underlying oxaliplatin resistance are still required to be explored. In the pre...
Guardat en:
| Publicat a: | Oncotarget |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Impact Journals LLC
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5844747/ https://ncbi.nlm.nih.gov/pubmed/29552311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24380 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|